Please login to the form below

Not currently logged in
Email:
Password:

NovoEight

This page shows the latest NovoEight news and features for those working in and with pharma, biotech and healthcare.

New data could unlock bigger market for Roche’s Hemlibra

New data could unlock bigger market for Roche’s Hemlibra

Novo Nordisk is developing a once-weekly version of its established NovoEight product - called N8-GP - that could be filed next year.

Latest news

  • US approval for Novo's Factor XIII drug Tretten US approval for Novo's Factor XIII drug Tretten

    In October, Novo secured US approval for NovoEight, a new long-acting Factor VIII for people with haemophilia A (turoctocog alfa), while it also has NN7999, a long-acting recombinant coagulation

  • Novo Nordisk wins US approval for haemophilia treatment Novo Nordisk wins US approval for haemophilia treatment

    US regulators have approved NovoEight, Novo Nordisk's new treatment for people with haemophilia A. ... The US approval follows a positive recommendation for NovoEight from the European Medicines Agency (EMA) made last month.

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    Novo Nordisk's haemophilia drug. Among the drugs backed by the CHMP, which provides guidance to the European Medicines Agency (EMA), was Novo Nordisk's NovoEight (turoctocog alfa) for use in ... NovoEight has also been filed for approval in the US, Japan,

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics